David Scott Carter

Person

Sunnyvale, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Oxaborole esters and uses thereof
- Patent number 11,578,087
- Issue date Feb 14, 2023
- Anacor Pharmaceuticals, Inc.
- Tsutomu Akama
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Beta adrenergic agonist and methods of using the same
- Patent number 11,040,944
- Issue date Jun 22, 2021
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Beta adrenergic agonist and methods of using the same
- Patent number 10,947,196
- Issue date Mar 16, 2021
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxaborole esters and uses thereof
- Patent number 10,882,872
- Issue date Jan 5, 2021
- Anacor Pharmaceuticals, Inc.
- Tsutomu Akama
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oxaborole esters and uses thereof
- Patent number 10,562,921
- Issue date Feb 18, 2020
- Anacor Pharmaceuticals, Inc.
- Tsutomu Akama
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diaminopyrimidines as P2X3 and P2X2/3 antagonists
- Patent number 9,556,127
- Issue date Jan 31, 2017
- Roćhe Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diaminopyrimidines as P2X3 and P2X2/3 antagonists
- Patent number 8,846,705
- Issue date Sep 30, 2014
- Roćhe Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using diaminopyrimidine as P2X3 and P2X⅔ receptor modula...
- Patent number 8,524,725
- Issue date Sep 3, 2013
- Roćhe Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic antiviral compounds
- Patent number 8,273,773
- Issue date Sep 25, 2012
- Roche Palo Alto LLC
- Kenneth Albert Brameld
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulat...
- Patent number 8,008,313
- Issue date Aug 30, 2011
- Roćhe Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Arylpiperazine derivatives and uses thereof
- Patent number 7,998,963
- Issue date Aug 16, 2011
- Roćhe Palo Alto LLC
- David Scott Carter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diaminopyrimidines as P2X3 and P2X2/3 antagonists
- Patent number 7,858,632
- Issue date Dec 28, 2010
- Roćhe Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Arylpiperazine derivatives and uses thereof
- Patent number 7,754,721
- Issue date Jul 13, 2010
- Roćhe Palo Alto LLC
- David Scott Carter
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20240352002
- Publication date Oct 24, 2024
- CuraSen Therapeutics, Inc.
- Jiaxin Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
- Publication number 20240158356
- Publication date May 16, 2024
- Roche Palo Alto LLC
- Chris Allen Broka
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHA1A-ADRENERGIC RECEPTOR AGONISTS AND METHODS OF USE
- Publication number 20230312524
- Publication date Oct 5, 2023
- CuraSen Therapeutics, Inc.
- David Scott Carter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMS AND COMPOSITIONS OF A BETA ADRENERGIC AGONIST
- Publication number 20230219892
- Publication date Jul 13, 2023
- CuraSen Therapeutics, Inc.
- Wei Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXABOROLE ESTERS AND USES THEREOF
- Publication number 20230132298
- Publication date Apr 27, 2023
- Anacor Pharmaceuticals, Inc.
- Tsutomu AKAMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
- Publication number 20230100975
- Publication date Mar 30, 2023
- Roche Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20220315534
- Publication date Oct 6, 2022
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20220169612
- Publication date Jun 2, 2022
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20210371380
- Publication date Dec 2, 2021
- CuraSen Therapeutics, Inc.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OXABOROLE ESTERS AND USES THEREOF
- Publication number 20210101916
- Publication date Apr 8, 2021
- Anacor Pharmaceuticals, Inc.
- Tsutomu AKAMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULAT...
- Publication number 20210008071
- Publication date Jan 14, 2021
- Roche Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
- Publication number 20210009531
- Publication date Jan 14, 2021
- Roche Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20200308114
- Publication date Oct 1, 2020
- CURASEN THERAPEUTICS, INC.
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
- Publication number 20200308115
- Publication date Oct 1, 2020
- Anthony P. Ford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
- Publication number 20200115347
- Publication date Apr 16, 2020
- Roche Palo Alto LLC
- Chris Allen Broka
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXABOROLE ESTERS AND USES THEREOF
- Publication number 20200017531
- Publication date Jan 16, 2020
- Anacor Pharmaceuticals, Inc.
- Tsutomu AKAMA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
- Publication number 20190270713
- Publication date Sep 5, 2019
- Roche Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
- Publication number 20190016688
- Publication date Jan 17, 2019
- Roche Palo Alto LLC
- Chris Allen Broka
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULAT...
- Publication number 20180311240
- Publication date Nov 1, 2018
- Roche Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
- Publication number 20180141919
- Publication date May 24, 2018
- Roche Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OXABOROLE ESTERS AND USES THEREOF
- Publication number 20170327519
- Publication date Nov 16, 2017
- Anacor Pharmaceuticals, Inc.
- Tsutomu AKAMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
- Publication number 20170096404
- Publication date Apr 6, 2017
- Roche Palo Alto LLC
- Chris Allen Broka
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULAT...
- Publication number 20160271131
- Publication date Sep 22, 2016
- Roche Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
- Publication number 20140357629
- Publication date Dec 4, 2014
- Roche Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULAT...
- Publication number 20130225570
- Publication date Aug 29, 2013
- Roche Palo Alto LLC
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING DIAMINOPYRIMIDINE AS P2X3 AND P2X2/3 RECEPTOR MODU...
- Publication number 20120122859
- Publication date May 17, 2012
- Roche Palo Alto LLC.
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
- Publication number 20110077242
- Publication date Mar 31, 2011
- Roche Palo Alto LLC.
- Chris Allen Broka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heterocyclic antiviral compounds
- Publication number 20100021423
- Publication date Jan 28, 2010
- Roche Palo Alto LLC.
- Kenneth Albert Brameld
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Arylpiperazine derivatives and uses thereof
- Publication number 20090209553
- Publication date Aug 20, 2009
- Roche Palo Alto LLC.
- David Scott Carter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Arylpiperazine derivatives and uses thereof
- Publication number 20080045543
- Publication date Feb 21, 2008
- David Scott Carter
- C07 - ORGANIC CHEMISTRY

David Scott Carter

Person

Patents Grantslast 30 patents

Oxaborole esters and uses thereof

Beta adrenergic agonist and methods of using the same

Beta adrenergic agonist and methods of using the same

Oxaborole esters and uses thereof

Oxaborole esters and uses thereof

Diaminopyrimidines as P2X3 and P2X2/3 antagonists

Diaminopyrimidines as P2X3 and P2X2/3 antagonists

Methods of using diaminopyrimidine as P2X3 and P2X⅔ receptor modula...

Heterocyclic antiviral compounds

Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulat...

Arylpiperazine derivatives and uses thereof

Diaminopyrimidines as P2X3 and P2X2/3 antagonists

Arylpiperazine derivatives and uses thereof

Patents Applicationslast 30 patents

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

ALPHA1A-ADRENERGIC RECEPTOR AGONISTS AND METHODS OF USE

FORMS AND COMPOSITIONS OF A BETA ADRENERGIC AGONIST

OXABOROLE ESTERS AND USES THEREOF

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

OXABOROLE ESTERS AND USES THEREOF

METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULAT...

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

OXABOROLE ESTERS AND USES THEREOF

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULAT...

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

OXABOROLE ESTERS AND USES THEREOF

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULAT...

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULAT...

METHODS OF USING DIAMINOPYRIMIDINE AS P2X3 AND P2X2/3 RECEPTOR MODU...

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

Heterocyclic antiviral compounds

Arylpiperazine derivatives and uses thereof

Arylpiperazine derivatives and uses thereof